Developing new prescription medicine for market is a costly and oftentimes, a futile endeavor as drugmakers can spend up to $2.6 billion only to see 12% of their candidates gain approval. When Pfizer fails on two out of three new drugs, retail investors have grown leery of the space, but companies like Aequus Pharmaceuticals (AQS.V) have found a way to bypass this massive regulatory and financial bottleneck by seeking out existing drugs approved in other countries and bringing them to Canada for market approval.
Spending 12-18 months rather than the standard 8-10 years for new drug approval, Aequus also benefits from low fixed costs that allow the company to profitably operate in a relatively small marketplace such as Canada in niche areas including neurology, ophthalmology and transplant. Positioned for growth with $2.0 million cash in the till, Aequus is a steady bet in an uncertain industry. As such, Equity Guru’s own Chris Parry spoke with company CEO and chairman, Doug Janzen, to get a better look at Aequus unique de-risked approach and its potential for investors. Tune in!
Short and Sweet (Ep 1) Brigadier Gold (BRG.V), PredictMedix (PMED.C), EarthRenew (ERTH.C) - The Jody Vance Experience
Aequus Pharmaceuticals (AQS.V) CEO, Doug Janzen - EG Interview Highlights
Aequus Pharmaceuticals (AQS.V) CEO, Doug Janzen - EG Interview Part 2
Sixth Wave Innovations (SIXW.C) Equity Guru Zoom Interview Part 2
Sixth Wave Innovations (SIXW.C) Equity Guru Zoom Interview Part 1
Pure Extracts Technologies (PULL.C) CEO explains extraction potential in multiple markets (Part 2)
Pure Extracts Technologies (PULL.C) CEO explains extraction potential in multiple markets (Part 1)
KWESST Micro Systems Inc - Zoom Interview with David Luxton Pt.3
KWESST podcast pt.2 – Executive Chairman David Luxton talks about laser warfare
Business, A.I. and the future of tech: a conversation with PredictMedix's (PMED.V) Kapil Raval
Investor alert: KWESST podcast pt.1 - a freakishly smart pre-IPO military tech company
Last Mile’s (MILE.V) E-scooters are turning into food delivery fleets
Last Mile’s (MILE.V) CEO Max Smith lays out his master plan: Equity Guru podcast pt.2
Last Mile’s (MILE.V) e-scooters are the perfect solution for college kids who don’t give a damn about cars: Equity Guru podcast pt.1 with Max Smith
Equity.Guru podcast: pt. 2 Yield Growth (BOSS.C) CEO Penny White talks about Urban Juve, topicals, mushrooms and more....
Equity.Guru podcast: pt. 1 Yield Growth (BOSS.C) CEO Penny White lays out her master plan
Equity.Guru Podcast: Mistakes were made - Jeanette VanderMarel's happy goodbye to Beleave
A Closer Look: Isracann BioSciences (IPOT.C) on growing pot in the Promised Land
A Closer Look: Ampd Gaming Technologies (AMPD.C) paves the way for Web 3.0
Copyright © 2006-2021 Podbean.com